Cleavage: The Rapid Division of the Zygote

Cleavage is the series of mitotic divisions that a fertilized egg undergoes immediately after Egg Activation and the Cell Cycle Restart, converting the single-celled zygote into a multicellular blastula. The defining feature is the decoupling of division from growth: in a typical somatic cell cycle, a cell roughly doubles its mass and biosynthetic capacity during G1 and S phase before it divides, so daughter cells are the same size as the parent. During cleavage, the cell divides without any such doubling — total cytoplasmic volume stays constant while the number of cells increases geometrically. Each division simply repackages the fixed store of egg cytoplasm into smaller units called blastomeres. This is possible because the egg was heavily provisioned during oogenesis. Ribosomes, tRNAs, histones, membrane precursors, and hundreds of maternal mRNAs and proteins — including the core cell-cycle machinery itself — are stockpiled in massive excess. Because the raw materials for S phase and M phase are already present, the embryo can skip the growth phases (G1 and G2) entirely and cycle directly between DNA synthesis (S) and mitosis (M). This compressed S-M-S-M cycle is often called the early embryonic cell cycle or, in Drosophila and Xenopus literature, the cleavage cycle, and it can be astonishingly fast: Xenopus laevis blastomeres complete a full division roughly every 30 minutes for the first ~12 cycles, and Drosophila melanogaster nuclei divide roughly every 8–10 minutes during the syncytial cleavage stage. A second core idea is the nucleocytoplasmic (N/C) ratio. As cleavage proceeds, total DNA content doubles with each division while cytoplasmic volume stays fixed, so the ratio of nuclear material to cytoplasm rises steadily. In most animals this rising ratio (or an associated titration of a maternal repressor) eventually triggers the midblastula transition (MBT): cell cycles lengthen, gap phases reappear, cell-cycle checkpoints are reinstated, and the zygotic genome is switched on for the first time. Cleavage is thus a bounded phase — it begins at fertilization and ends when the embryo's own genome takes over control of its cell cycle, a transition foreshadowed here and treated fully under Blastula Formation and the Blastocoel.

1. The maternal oscillator: Cdk1–cyclin B and MPF. The molecular engine of cleavage is Maturation/M-phase Promoting Factor (MPF), a complex of the kinase Cdk1 (Cdc2) bound to a regulatory subunit, cyclin B. During interphase of each cleavage cycle, cyclin B accumulates through continuous translation of stockpiled maternal cyclin B mRNA. Cyclin B binds Cdk1, but the complex is held inactive by inhibitory phosphorylation of Cdk1 (on Thr14/Tyr15, added by the kinases Wee1/Myt1). As cyclin B levels cross a threshold, the phosphatase Cdc25 removes these inhibitory phosphates, switching MPF on in a highly nonlinear, switch-like fashion (a positive feedback loop, since active Cdk1 further activates Cdc25 and inhibits Wee1). Active MPF phosphorylates hundreds of substrates that trigger nuclear envelope breakdown, chromosome condensation, spindle assembly, and entry into mitosis.

2. Resetting the clock: cyclin destruction. Mitosis must end, and it does so because MPF activity is abruptly destroyed. The Anaphase-Promoting Complex/Cyclosome (APC/C), a large E3 ubiquitin ligase, is activated during metaphase/anaphase and tags cyclin B with ubiquitin chains, marking it for destruction by the 26S proteasome. Cyclin B levels collapse within minutes, MPF activity falls to zero, chromosomes decondense, the nuclear envelope reforms, and the cell exits mitosis. Because maternal cyclin B mRNA is still present and translation resumes immediately, cyclin B protein begins re-accumulating right away — the oscillator is self-restarting, cycling autonomously without needing new transcription or external growth signals. This periodic rise-and-catastrophic-fall of cyclin B/MPF is the literal clock of cleavage; its period sets the length of each cleavage division.

3. No G1, no G2, no checkpoints. In a somatic cycle, checkpoints monitor DNA damage and cell size before allowing progression past G1/S and G2/M boundaries. Early cleavage cycles largely lack these checkpoints — the DNA damage checkpoint and the spindle assembly checkpoint are present but weak or delayed in their action, and there is no size-sensing G1 checkpoint at all, because "cell size" simply is not being regulated; blastomeres are allowed to shrink with each round. This is why cleavage-stage embryos are unusually tolerant of chromosomal abnormalities and can proceed through several divisions even with damaged DNA — a fact directly relevant to early embryo screening in assisted reproduction.

4. Geometric partitioning and furrow placement. Each division splits the existing cytoplasm, not doubles it, so blastomere volume roughly halves at every round while total embryonic volume remains constant (aside from a small amount of extracellular fluid or shell space). The plane and position of each cleavage furrow are set mechanically by the mitotic spindle: astral microtubules radiating from the two centrosomes signal to the cell cortex, positioning a band of actin and myosin II (the contractile ring) at the cell equator, midway between the two spindle poles. Local RhoA GTPase activation at the equator, downstream of signals from the central spindle (the anaphase midzone) and the astral microtubules, triggers actomyosin ring assembly and contraction, pinching the cell in two — cytokinesis. Because the first few cleavage divisions in most embryos alternate orientation (first division vertical, second division vertical but perpendicular to the first, third division horizontal), a stereotyped early cleavage pattern emerges, previewed here and detailed under Cleavage Patterns Across Taxa.

5. The nucleocytoplasmic ratio and MBT. Each S phase doubles the amount of nuclear DNA, but cytoplasmic volume is fixed, so the ratio of DNA (or histone-binding capacity, or some other titratable nuclear component) to cytoplasm climbs roughly two-fold every cycle. In Xenopus, this ratio is thought to be sensed via titration of maternal proteins — such as the histones that normally bind and repress chromatin, or checkpoint kinases like Chk1 that become activated as replication origins compete for limiting replication factors — against the growing amount of DNA. When a threshold N/C ratio is reached (around cycle 12 in Xenopus, at roughly 4,096 cells), cell cycles slow, gap phases appear, and zygotic genome activation (ZGA) begins in earnest. This marks the functional end of the cleavage period.

Hertwig and Rugh: cleavage proceeds without added growth. Oscar Hertwig's late-19th-century observations and later quantitative work by Roberts Rugh on Xenopus and Rana established the basic descriptive fact at the heart of this article: total embryonic volume at the 2-cell, 4-cell, 8-cell, and later stages remains essentially equal to the volume of the unfertilized egg, while cell number rises geometrically (2, 4, 8, 16…). This ruled out a naive model in which each blastomere first grows to the size of its parent before dividing, and it framed the central question — what clock, if not growth, controls the timing of division?

Masui and Markert (1971), and the discovery of MPF. Yoshio Masui and Clement Markert performed the decisive experiment showing that a diffusible cytoplasmic factor, not gene transcription, drives the meiotic and mitotic divisions of the frog oocyte/egg. They took cytoplasm from a Xenopus oocyte that had matured (undergone germinal vesicle breakdown in response to progesterone) and injected a small amount into an immature oocyte that had never been exposed to hormone. The recipient oocyte underwent germinal vesicle breakdown and matured anyway. Because the injected volume was tiny and contained no significant new transcription, this proved that maturation is driven by a transferable cytoplasmic activity — which Masui and Markert named Maturation Promoting Factor (MPF). Later biochemical work (Lohka, Maller, and others through the 1980s) identified MPF as the Cdk1–cyclin B complex, showing the same activity also drives mitotic M-phase entry in cleaving embryos — hence the dual name Maturation/M-phase Promoting Factor.

Cyclin discovery: Evans, Hunt, and the sea urchin embryo. Tim Hunt, working with sea urchin (and later clam) embryos, made a parallel and equally decisive observation in 1983. Monitoring newly synthesized proteins by labeling embryos with radioactive methionine and running samples on gels at successive time points after fertilization, he noticed one protein band whose intensity rose steadily through interphase and then abruptly disappeared at each cell division, only to reaccumulate in the next cycle — precisely in step with mitosis. He called this protein cyclin (later, cyclin B). Crucially, this periodic destruction happened even when protein synthesis was blocked with cycloheximide partway through a cycle, showing that an active degradation mechanism — not merely dilution — removed the protein at each division. This directly demonstrated the "sawtooth" oscillation central to the mechanism above, and Hunt shared the 2001 Nobel Prize in Physiology or Medicine with Paul Nurse and Leland Hartwell for this and related cell-cycle discoveries.

Cell-fusion and injection experiments confirming a diffusible trigger. Complementary classical experiments used cell fusion: fusing a mitotic cell with an interphase cell drives the interphase nucleus into premature chromosome condensation, showing that a cytoplasmic factor (later understood to be MPF) is sufficient to impose M-phase state on a nucleus regardless of that nucleus's own cycle stage. Applied to early embryos, cytoplasmic transfer and cyclin mRNA injection experiments (Murray and Kirschner, using cell-free Xenopus egg extracts in the late 1980s) showed that extracts could execute repeated, self-sustaining cell-cycle oscillations — nuclear envelope breakdown and reformation, chromosome condensation and decondensation — in a test tube, with no nuclei, no transcription, and no cell structure at all, driven purely by cyclical synthesis and destruction of cyclin protein added to the extract. This is perhaps the single most powerful piece of evidence that cleavage-cycle timing is an autonomous biochemical oscillator built from maternal components, entirely separable from normal cellular growth control.

Satya-Prakash / Newport-Kirschner and the midblastula transition. John Newport and Marc Kirschner (1982) showed experimentally that the trigger for MBT in Xenopus is the ratio of nuclear (DNA) content to cytoplasmic volume, not a fixed number of divisions or elapsed time. They manipulated the amount of DNA present per embryo — by altering ploidy (haploid vs. diploid vs. tetraploid embryos) or by adding extra DNA (sperm chromatin) — and found that embryos with more DNA per cell activated zygotic transcription and slowed their cell cycles earlier (after fewer divisions), while embryos with less DNA per cell relative to cytoplasm delayed MBT. This established the N/C-ratio-sensing model described in the mechanism section, converting the earlier phenomenological observation of a "12th cleavage" rule into a titration mechanism.

Example 1 — Counting blastomeres and estimating cell volume. A Xenopus laevis egg has a diameter of about 1.2 mm, giving a volume of V = (4/3)πr³ = (4/3)π(0.6 mm)³ ≈ 0.905 mm³. Suppose cleavage proceeds synchronously (equal, simultaneous divisions) for the first 12 cycles before MBT, as is roughly true in Xenopus.

• After cycle 1: 2 cells
• After cycle 2: 4 cells
• After cycle n: 2ⁿ cells

After 12 cycles: 2¹² = 4,096 cells. Assuming the total embryonic volume stays fixed at ≈0.905 mm³ (the core claim of cleavage), the average blastomere volume after 12 divisions is 0.905 mm³ / 4,096 ≈ 2.2 × 10⁻⁴ mm³, corresponding to a cell diameter of roughly d = (6V/π)^(1/3) ≈ (6 × 2.2×10⁻⁴ / π)^(1/3) mm ≈ 0.075 mm (75 μm). So a blastomere at the 4,096-cell stage is about 1/16 the diameter of the original egg (1200 μm → ~75 μm), even though its DNA content per genome-equivalent is unchanged — a direct numerical illustration of "division without growth." This also shows why the N/C ratio has risen 4,096-fold in nuclear-to-cytoplasmic DNA terms relative to the zygote (2 genome copies in one large cytoplasm vs. 2 genome copies in a cytoplasm 1/4096th the size), consistent with the Newport–Kirschner titration model.

Example 2 — Interpreting a cyclin-destruction experiment. An investigator fertilizes sea urchin eggs and, at time t = 0, adds cycloheximide (a protein synthesis inhibitor) to one batch while leaving a control batch untreated. The investigator then monitors both a cyclin-B-specific Western blot and cell divisions over the next 90 minutes, expecting to distinguish two hypotheses:

• Hypothesis A: cyclin B is simply diluted out passively as the cell divides (no active degradation).
• Hypothesis B: cyclin B is actively synthesized during interphase and specifically destroyed by a regulated proteolytic mechanism at each M-phase (the APC/C-ubiquitin-proteasome pathway).

Result: in the control (untreated) embryos, cyclin B rises steadily through interphase and then sharply collapses to near-zero at each division, before rising again in the next cycle — a repeating sawtooth, not a step-down staircase that dilution would produce. In the cycloheximide-treated embryos (no new protein synthesis allowed), cyclin B present at t = 0 still drops sharply at the time the control embryos enter mitosis, and it does so to the same low level, even though no new cyclin is being made to "reset" a dilution baseline. Because cyclin disappears completely rather than being progressively halved cycle after cycle (which passive dilution across roughly equal-sized daughter cells would produce only a ~50% drop per division, not a near-total collapse), the data support Hypothesis B: an active, regulated proteolytic mechanism (the APC/C tagging cyclin B for proteasomal destruction) drives cyclin's disappearance at each mitosis, exactly as Hunt's original sea urchin experiments showed. This reasoning is the logical backbone of how the discovery of cyclin destruction was actually established.

Yoshio Masui trained in Japan before moving to North America, where he pursued a question that had puzzled embryologists for decades: what actually tells an oocyte, sitting arrested for months or years, that it is time to resume meiosis and prepare for fertilization? Working with Clement Markert at Yale in the late 1960s and early 1970s, Masui used the classic amphibian oocyte system — large, easily manipulated Rana pipiens and Xenopus laevis oocytes — and the simple but powerful tool of microinjection. Their 1971 cytoplasmic transfer experiment (mature cytoplasm injected into immature oocytes triggers maturation) is one of the cleanest demonstrations in developmental biology that a diffusible molecular factor, rather than a nuclear or genetic signal, can impose a cell-cycle transition. Masui continued working on MPF's properties for years before its molecular identity as Cdk1–cyclin B was worked out biochemically by others, including James Maller's and Manfred Lohka's laboratories. Masui's careful, minimal, mechanistically decisive style of experiment — inject a small defined cytoplasmic sample, observe a discrete developmental switch — became a template for cell-cycle research generally, and MPF stands as one of the founding concepts connecting oocyte biology to the universal eukaryotic cell cycle.

Assisted reproduction and embryo screening. Human IVF embryos undergo the same growth-free cleavage logic — the early divisions rely heavily on maternal stores, and the embryo's own genome is not fully active until roughly the 4–8 cell stage in humans (a comparatively early zygotic genome activation relative to frogs). Clinics assess embryo quality partly by tracking cleavage timing (time-lapse imaging of when each division occurs), because abnormal cleavage kinetics — divisions that are too fast, too slow, or asynchronous — correlate with chromosomal mosaicism and reduced implantation potential. Preimplantation genetic testing exploits the fact that a blastomere biopsied at the cleavage stage can be genetically representative of the rest of the embryo.

Cancer biology and cell-cycle drugs. The core molecular players discovered through cleavage research — Cdk1, cyclin B, the APC/C, Wee1, Cdc25 — are the same regulators that, when dysregulated, contribute to unchecked proliferation in cancer. Wee1 inhibitors and CDK inhibitors used or in trials as anticancer agents directly target this ancient cyclin-Cdk oscillator first dissected in frog and sea urchin cleavage systems.

Cell-free systems in biotechnology. The Xenopus egg extract system, developed to study the autonomous cleavage-cycle oscillator, remains a workhorse for reconstituting DNA replication, chromosome segregation, and nuclear assembly outside of cells — used in basic research on genome stability and in drug-screening pipelines for cell-cycle-targeted therapeutics.

Aquaculture and conservation. Understanding cleavage kinetics and the N/C-ratio trigger for genome activation informs polyploidy induction (e.g., triploid fish and shellfish production for sterile, faster-growing aquaculture stock) and cryopreservation protocols for embryos of endangered amphibians and fish, where correct staging relative to cleavage and MBT is essential for successful thawing and continued development.

Ask the tutor: How does the nucleocytoplasmic ratio actually get "sensed" at the molecular level to trigger the midblastula transition?